S&P 500   3,627.90 (-0.21%)
DOW   29,858.62 (-0.62%)
QQQ   296.13 (+0.56%)
AAPL   115.92 (+0.65%)
MSFT   213.90 (+0.02%)
FB   275.58 (-0.48%)
GOOGL   1,764.23 (+0.02%)
AMZN   3,180.70 (+2.01%)
TSLA   571.41 (+2.89%)
NVDA   529.46 (+2.15%)
BABA   276.39 (-1.28%)
CGC   26.94 (-0.11%)
GE   10.51 (+0.57%)
MU   63.58 (-0.58%)
AMD   86.95 (+2.21%)
T   28.91 (-1.09%)
NIO   52.99 (-0.97%)
F   9.03 (-4.44%)
ACB   8.82 (-4.44%)
NFLX   484.33 (+0.30%)
GILD   59.52 (-1.21%)
BA   218.07 (-0.19%)
DIS   148.75 (-1.81%)
S&P 500   3,627.90 (-0.21%)
DOW   29,858.62 (-0.62%)
QQQ   296.13 (+0.56%)
AAPL   115.92 (+0.65%)
MSFT   213.90 (+0.02%)
FB   275.58 (-0.48%)
GOOGL   1,764.23 (+0.02%)
AMZN   3,180.70 (+2.01%)
TSLA   571.41 (+2.89%)
NVDA   529.46 (+2.15%)
BABA   276.39 (-1.28%)
CGC   26.94 (-0.11%)
GE   10.51 (+0.57%)
MU   63.58 (-0.58%)
AMD   86.95 (+2.21%)
T   28.91 (-1.09%)
NIO   52.99 (-0.97%)
F   9.03 (-4.44%)
ACB   8.82 (-4.44%)
NFLX   484.33 (+0.30%)
GILD   59.52 (-1.21%)
BA   218.07 (-0.19%)
DIS   148.75 (-1.81%)
S&P 500   3,627.90 (-0.21%)
DOW   29,858.62 (-0.62%)
QQQ   296.13 (+0.56%)
AAPL   115.92 (+0.65%)
MSFT   213.90 (+0.02%)
FB   275.58 (-0.48%)
GOOGL   1,764.23 (+0.02%)
AMZN   3,180.70 (+2.01%)
TSLA   571.41 (+2.89%)
NVDA   529.46 (+2.15%)
BABA   276.39 (-1.28%)
CGC   26.94 (-0.11%)
GE   10.51 (+0.57%)
MU   63.58 (-0.58%)
AMD   86.95 (+2.21%)
T   28.91 (-1.09%)
NIO   52.99 (-0.97%)
F   9.03 (-4.44%)
ACB   8.82 (-4.44%)
NFLX   484.33 (+0.30%)
GILD   59.52 (-1.21%)
BA   218.07 (-0.19%)
DIS   148.75 (-1.81%)
S&P 500   3,627.90 (-0.21%)
DOW   29,858.62 (-0.62%)
QQQ   296.13 (+0.56%)
AAPL   115.92 (+0.65%)
MSFT   213.90 (+0.02%)
FB   275.58 (-0.48%)
GOOGL   1,764.23 (+0.02%)
AMZN   3,180.70 (+2.01%)
TSLA   571.41 (+2.89%)
NVDA   529.46 (+2.15%)
BABA   276.39 (-1.28%)
CGC   26.94 (-0.11%)
GE   10.51 (+0.57%)
MU   63.58 (-0.58%)
AMD   86.95 (+2.21%)
T   28.91 (-1.09%)
NIO   52.99 (-0.97%)
F   9.03 (-4.44%)
ACB   8.82 (-4.44%)
NFLX   484.33 (+0.30%)
GILD   59.52 (-1.21%)
BA   218.07 (-0.19%)
DIS   148.75 (-1.81%)
Log in
NASDAQ:MBII

Marrone Bio Innovations Short Interest Ratio and Short Volume

$1.20
+0.04 (+3.45 %)
(As of 11/25/2020 02:50 PM ET)
Add
Compare
Today's Range
$1.18
Now: $1.20
$1.26
50-Day Range
$1.10
MA: $1.16
$1.26
52-Week Range
$0.61
Now: $1.20
$1.50
Volume11,557 shs
Average Volume185,927 shs
Market Capitalization$182.97 million
P/E RatioN/A
Dividend YieldN/A
Beta0.29

Short Interest

Marrone Bio Innovations (NASDAQ:MBII) Short Interest Data

Current Short Volume:1,900,000 shares
Previous Short Volume:1,940,000 shares
Change Vs. Previous Month:-2.06%
Dollar Volume Sold Short:$2.09 million
Short Interest Ratio / Days to Cover:15.0
Last Record Date:October, 30 2020
Outstanding Shares:110,730,000 shares
Float Size:92,440,000 shares
Short Percent of Float:2.06%
Today's Trading Volume:11,557 shares
Average Trading Volume:185,927 shares
Today's Volume Vs. Average:-93.78%



Marrone Bio Innovations (NASDAQ:MBII) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
10/30/20201,900,000 $2.09 million -2.1%2.1%15.2$1.10
10/15/20201,940,000 $2.29 million -1.0%2.1%14.1$1.18
9/30/20201,960,000 $2.27 million -3.0%2.1%15$1.16
9/15/20202,020,000 $2.38 million -4.3%2.2%12.3$1.18
8/31/20202,110,000 $2.43 million -11.3%2.3%12.1$1.15
8/14/20202,380,000 $2.95 million -1.7%2.6%12$1.24
7/31/20202,420,000 $3.48 million 7.6%2.7%10.3$1.44
7/15/20202,250,000 $2.50 million -5.1%2.5%8.7$1.11
6/30/20202,370,000 $2.68 million 9.7%2.6%8.4$1.13
6/15/20202,160,000 $2.42 million -21.2%2.4%8.1$1.12
5/29/20202,740,000 $2.79 million -8.4%3.1%9.8$1.02
5/15/20202,990,000 $3.20 million -6.9%3.3%11.4$1.07
4/30/20203,210,000 $3.11 million 7.4%3.7%14$0.97
4/15/20202,990,000 $2.93 million 6.0%3.3%16.4$0.98
3/31/20202,820,000 $1.97 million -0.4%3.1%16.7$0.70
3/13/20202,831,500 $1.98 million -4.0%3.6%17.2$0.70
2/28/20202,950,000 $2.33 million 2.1%3.8%19.5$0.79
2/14/20202,890,000 $2.69 million 0.7%3.5%19.9$0.93
1/31/20202,870,000 $3.27 million 0.4%3.5%20.5$1.14
1/15/20202,860,000 $3.26 million 11.3%3.5%20.5$1.14
12/31/20192,570,000 $3.14 million 0.8%3.1%20$1.22

Marrone Bio Innovations (NASDAQ:MBII) Short Interest FAQ

speech bubbles
speech bubbles











What is Marrone Bio Innovations' current short interest?

Short interest is the volume of Marrone Bio Innovations shares that have been sold short but have not yet been covered or closed out. As of October 30th, traders have sold 1,900,000 shares of MBII short. 2.06% of Marrone Bio Innovations' shares are currently sold short. View details.

What is a good short interest ratio for Marrone Bio Innovations?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Marrone Bio Innovations currently has a short interest ratio of 15.0.

What is a good short interest percentage for Marrone Bio Innovations?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.06% of Marrone Bio Innovations' floating shares are currently sold short.

Is Marrone Bio Innovations' short interest increasing or decreasing?

Marrone Bio Innovations saw a decrease in short interest during the month of October. As of October 30th, there was short interest totaling 1,900,000 shares, a decrease of 2.1% from the previous total of 1,940,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Marrone Bio Innovations' float size?

Marrone Bio Innovations currently has issued a total of 152,477,000 shares. Some of Marrone Bio Innovations' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Marrone Bio Innovations currently has a public float of 92,440,000 shares.

How does Marrone Bio Innovations' short interest compare to its competitors?

2.06% of Marrone Bio Innovations' shares are currently sold short. Here is how the short interest of companies in the industry of "agricultural chemicals" compare to Marrone Bio Innovations: Nutrien Ltd. (0.71%), The Scotts Miracle-Gro Company (2.27%), The Mosaic Company (2.58%), CF Industries Holdings, Inc. (2.22%), ICL Group Ltd (0.09%), CVR Partners, LP (0.10%), American Vanguard Co. (1.47%), Calyxt, Inc. (3.25%), Evogene Ltd. (1.16%), and China Green Agriculture, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.66 billion), Aon Plc ($3.83 billion), Analog Devices, Inc. ($3.33 billion), ViacomCBS Inc. ($3.13 billion), Snap Inc. ($3.05 billion), The Clorox Company ($2.85 billion), Uber Technologies, Inc. ($2.80 billion), Moderna, Inc. ($2.26 billion), Simon Property Group, Inc. ($2.02 billion), and International Flavors & Fragrances Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short Marrone Bio Innovations stock?

Short selling MBII is an investing strategy that aims to generate trading profit from Marrone Bio Innovations as its price is falling. Marrone Bio Innovations' stock is trading up $0.04 today. To short Marrone Bio Innovations stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Marrone Bio Innovations will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Marrone Bio Innovations?

A short squeeze for Marrone Bio Innovations occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MBII, which in turn drives the price of the stock up even further.

How often is Marrone Bio Innovations' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MBII, twice per month. The most recent reporting period available is October, 30 2020.


This page was last updated on 11/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.